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Abstract 
The catalytically competent Mn(II)-loaded form of the argE-encoded N-acetyl-l-ornithine deacetylase from 
Escherichia coli (ArgE) was characterized by kinetic, thermodynamic, and spectroscopic methods. Maximum N-
acetyl-l-ornithine (NAO) hydrolytic activity was observed in the presence of one Mn(II) ion with k cat and K m 
values of 550 s−1 and 0.8 mM, respectively, providing a catalytic efficiency (k cat/K m) of 6.9 × 105 M−1 s−1. The ArgE 
dissociation constant (K d) for Mn(II) was determined to be 0.18 μM, correlating well with a value obtained by 
isothermal titration calorimetry of 0.30 μM for the first metal binding event and 5.3 μM for the second. An 
Arrhenius plot of the NAO hydrolysis for Mn(II)-loaded ArgE was linear from 15 to 55 °C, suggesting the rate-
limiting step does not change as a function of temperature over this range. The activation energy, determined 
from the slope of this plot, was 50.3 kJ mol−1. Other thermodynamic parameters were ΔG ‡ = 58.1 kJ mol−1, ΔH 
‡ = 47.7 kJ mol−1, and ΔS ‡ = –34.5 J mol−1 K−1. Similarly, plots of lnK m versus 1/T were linear, suggesting substrate 
binding is controlled by a single step. The natural product, [(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]leucine 
(bestatin), was found to be a competitive inhibitor of ArgE with a K i value of 67 μM. Electron paramagnetic 
resonance (EPR) data recorded for both [Mn(II)_(ArgE)] and [Mn(II)Mn(II)(ArgE)] indicate that the two Mn(II) 
ions form a dinuclear site. Moreover, the EPR spectrum of [Mn(II)Mn(II)(ArgE)] in the presence of bestatin 
indicates that bestatin binds to ArgE but does not form a µ-alkoxide bridge between the two metal ions. 
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Abbreviations 
AAP  Leucine aminopeptidase from Aeromonas proteolytica (Vibrio proteolyticus) 
ArgE  argE-encoded N-acetyl-l-ornithine deacetylase 
Bestatin [(2S,3R)-3-Amino-2-hydroxy-4-phenylbutanoyl]leucine 
blLAP  Bovine lens leucine aminopeptidase 
CPG2  Carboxypeptidase G2 from Pseudomonas sp. strain RS-16 
DapE  N-Succinyl-l,l-diaminopimelic acid desuccinylase 
EPR  Electron paramagnetic resonance 
HEPES  4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid 
ITC  Isothermal titration calorimetry 
NAO  N-Acetyl-l-ornithine 
Introduction 
The emergence of antibiotic-resistant bacterial infections has created a significant and growing medical problem 
in the USA and throughout the world [1, 2, 3, 4]. Antibiotic resistance has been recognized since the introduction 
of penicillin more than 50 years ago when penicillin-resistant infections caused by Staphylococcus aureus rapidly 
appeared [3, 5]. Because bacteria have been exposed to many of the currently available antibiotics, such as β-
lactams, fluoroquinolones, macrolides, tetracyclines, aminoglycosides, glycopeptides, or trimethoprim 
combinations, for years, they have evolved resistance to these drugs [3, 6, 7, 8, 9]. In fact, several bacterial 
infections, some of which were thought to have been eradicated, have made a significant resurgence owing to 
bacterial resistance to antibiotics. These illnesses include, but are not limited to, tuberculosis, staph infections, 
and childhood bacterial meningitis or ear infections [3, 5]. In addition to its adverse effect on public health, 
antimicrobial resistance contributes to higher health care costs. Treating resistant infections often requires the 
use of more expensive or more toxic drugs, such as colistin, and can result in longer hospital stays for infected 
patients [10]. The Institute of Medicine, a part of the National Academy of Sciences, has estimated that the 
annual cost of treating antibiotic-resistant infections in the USA may be as high as $30 billion [1]. Since many of 
the broad-spectrum antibiotics contain β-lactam functional units that target enzymes involved in bacterial cell 
wall synthesis or pathways involved in cell replication [3, 5], new enzymatic targets must be located so novel 
inhibitors can be synthesized, providing new classes of antibiotics. For this reason, several bacterial 
metallohydrolases containing dinuclear active sites have become the subject of intense efforts in inhibitor 
design [11, 12, 13, 14, 15, 16]. 
 
The argE-encoded N-acetyl-l-ornithine deacetylase (ArgE) is a bacterial metallohydrolase that contains a 
dinuclear active site and is a member of the arginine biosynthetic pathway in bacteria [17]. Prokaryotes 
synthesize arginine through a series of eight enzyme-catalyzed reactions that differ from those of eukaryotes in 
two key steps: (1) acetylation of glutamate and (2) the subsequent deacetylation of the arginine precursor N-
acetyl-l-ornithine (NAO) by ArgE [18]. Because ornithine is required, not only for the synthesis of arginine in 
bacteria, but also for polyamines involved in DNA replication and cell division, NAO deacetylation is critical for 
bacterial proliferation [19]. Indeed, when Meinnel et al. [20] transformed an arginine auxotrophic bacterial 
strain void of NAO deacetylase activity with a plasmid containing argE, an Arg+ phenotype resulted [20]. 
However, when the start codon (ATG) of argE in the same plasmid was changed to the Amber codon (TAG), the 
resultant plasmid was unable to relieve arginine auxotrophy in the same cell strain; therefore, ArgE is required 
for cell viability. Given the fact that ArgE is only found in prokaryotes and is required for bacterial cell growth 
and proliferation, it represents an enzymatic target for a novel class of antibacterial pharmaceuticals [19]. 
 
Though little is currently known about ArgE, it shares high sequence homology with several dinuclear 
metallopeptidases in family M28, some of which have been characterized in detail using kinetic, spectroscopic, 
and crystallographic methods [21]. High-resolution X-ray crystal structures of the leucine aminopeptidase from 
Aeromonas proteolytica (Vibrio proteolyticus) (AAP) [22] and the carboxypeptidase G2 from Pseudomonas sp. 
strain RS-16 (CPG2) [23] revealed that these enzymes contain nearly identical active sites. To date, no X-ray 
crystallographic data have been reported for ArgE; however, all of the amino acids that function as metal ligands 
in AAP and CPG2 are fully conserved in ArgE [21]. AAP and other M28 family members are competitively 
inhibited by synthetic small molecules classified as boronic acids [24, 25, 26], chloromethyl ketones [27], 
phosphonic acids [28, 29, 30], hydroxamates [31, 32, 33], and β-hydroxyamides [27]. The number of compounds 
isolated from natural sources capable of inhibiting aminopeptidases is also increasing. For instance, [(2S,3R)-3-
amino-2-hydroxy-4-phenylbutanoyl]leucine (bestatin), a dipeptide isolated from cultures of Streptomyces 
olivoreticuli [34], exhibits slow-binding inhibition towards bovine lens leucine aminopeptidase (blLAP) and AAP 
with K i * values of 1.3 and 18 nM, respectively [35]. These small molecule inhibitors are effective owing to 
complexation of the active-site metal ions and this complexation is a function of both the particular metal ion 
involved and the catalytic mechanism of the enzyme. In order to determine if ArgE can be activated by Mn(II) 
ions, similar to blLAP [36], we have examined the Mn(II)-loaded ArgE enzyme from Escherichia coli using both 
kinetic and spectroscopic methods. These data indicate that ArgE can be activated by Mn(II) ions and confirm 
that dinuclear Mn(II) centers are formed. These data also provide additional information regarding the 
enzymatic mechanism of ArgE, an important precursor to the rational design of a new class of ArgE inhibitors 
that potentially exhibit therapeutic functions. 
Materials and methods 
Enzyme expression and purification 
All chemicals used in this study were purchased from commercial sources and were of the highest quality 
available. ArgE from E. coli was purified as previously described [17] from a stock culture provided by John 
Blanchard [21]. The purified enzyme exhibited a single band on a 12% sodium dodecyl sulfate polyacrylamide gel 
electrophoresis gel, which corresponds to its calculated M r of 42,350, by comparison with molecular weight 
standards purchased from Sigma. It was subsequently concentrated to below 1 mM and stored at 4 °C. Protein 
concentrations were determined using the theoretical value ε 280 = 41,250 M−1 cm−1 [37]. 
 
Preparation of apo enzymes 
Divalent metal ions were removed from ArgE by dialysis against more than 500 vol of 10 mM EDTA in 25 mM 4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.5, for at least 48 h at 4 °C. EDTA was removed by 
extensive dialysis against 50 mM Chelex-100 treated HEPES buffer, pH 7.5, at 4 °C. Metals were removed from 
all dialysisware by incubation in 10 mM EDTA, pH 8.0, for more than 48 h. HEPES was made “metal-free” by 
passing it through a Chelex-100 column. ArgE thus treated was inactive and found to contain no detectable 
metals ions via inductively coupled plasma atomic emission spectrometry. 
 
Enzymatic assay of ArgE 
Unless otherwise noted, enzyme kinetic constants were determined in 50 mM Chelex-100 treated sodium 
phosphate buffer, pH 7.5, with NAO as the substrate at 25 °C. The rate of NAO deacetylation was monitored as a 
decrease in absorbance at 214 nm. Catalytic activities were determined within ±10%. Initial rates were fit 
directly to the Michaelis–Menten equation to obtain the catalytic constants K m and k cat. The monosubstituted 
species [Mn(II)_(ArgE)] was prepared by incubating apo-ArgE with one stoichiometric equivalent of metal, while 
the disubstituted species [Mn(II)Mn(II)(ArgE)] was generated by incubating apo enzyme with 2 equiv of Mn(II) 
for approximately 20 min at 25 °C. 
 
Isothermal titration calorimetry 
Isothermal titration calorimetry (ITC) measurements were carried out on a MicroCal OMEGA ultrasensitive 
titration calorimeter. The divalent metal ion titrant and apo enzyme solutions were prepared in Chelex-100 
treated 25 mM HEPES buffer, pH 7.5. Stock buffer solutions were thoroughly degassed before each titration. The 
enzyme solution (70 μM) was placed in the calorimeter cell and stirred at 200 rpm to ensure rapid mixing. 
Typically, 4–6 μL of titrant was delivered over 7.6 s with a 6-min interval between injections to allow for 
complete equilibration. Each titration was continued until 4.5–6 equiv of Mn(II) had been added to ensure that 
no additional complexes were formed in excess titrant. A background titration, consisting of the identical titrant 
solution but only the buffer solution in the sample cell, was subtracted from each experimental titration to 
account for the heat of dilution. These data were analyzed with a two-site binding model by the Windows-based 
Origin software package supplied by MicroCal. The equilibrium binding constant, K a, and the enthalpy change, 
ΔH, were used to calculate ΔG and ΔS using the Gibbs free energy relationship (Eq. 1):  
 
∆𝐺𝐺∘ = −𝑅𝑅𝑅𝑅𝐾𝐾a = ∆𝐻𝐻∘ − 𝑅𝑅∆𝑆𝑆∘  (1) 
 
where R = 1.9872 cal mol−1 K−1. The relationship between K a and K d is defined as  
 
𝐾𝐾d = 1/𝐾𝐾a   (2) 
 
Individual ArgE solutions were prepared by diluting stock enzyme solutions in 25 mM Chelex-100 treated HEPES 
buffer, pH 7.6, containing 150 mM KCl. 
 
Spectroscopic measurements 
Kinetic data were recorded using a Shimadzu UV-3101PC spectrophotometer. The temperature of assay 
solutions and that of the cuvette cavity were maintained by a circulating water bath (Isotemp 20130D, Fischer 
Scientific). Low-temperature electron paramagnetic resonance (EPR) spectroscopy was performed using a 
Bruker Elexsys E500 spectrometer equipped with an ER 4116 DM dual-mode X-band cavity and an Oxford 
Instruments ESR-900 helium-flow cryostat. Background spectra recorded on a buffer sample were aligned with 
and subtracted from experimental spectra as described previously [38, 39]. EPR spectra were recorded with 20-
mW microwave power (in a Bruker ER4116DM cavity in B microwave ⊥ B static mode) at 9.6330 ± 0.0005 GHz, 6–30 K, 
and with 10.6 G magnetic field modulation at 100 kHz. The species termed here “[Mn(II)_(ArgE)]” and 
“[Mn(II)Mn(II)(ArgE)]” correspond to apo-ArgE to which 1 and 2 equiv of Mn(II) were added, respectively; 
[Mn(II)Zn(II)(ArgE)] denotes ArgE to which first 1 equiv of Mn(II) was added, followed by 1 equiv of Zn(II), and 
[Zn(II)Mn(II)(ArgE)] refers to ArgE to which first 1 equiv of Zn(II) was added, followed by 1 equiv of Mn(II). 
Results 
Catalytic activity of Mn(II)-loaded ArgE 
Incubation of apo-ArgE with 1 equiv of Mn(II) produced an enzyme with a k cat value of 550 s−1, which is 2.8-fold 
lower than that observed for [Zn(II)_(ArgE)] and 4.6-fold lower than for [Co(II)_(ArgE)] [17] (Table 1). The 
observed K m value for NAO binding to [Mn(II)_ArgE] is identical (0.8 mM) within error to that observed for 
Zn(II)-loaded ArgE. The k cat value for NAO hydrolysis by ArgE as a function of Mn(II) concentration was also 
examined. In these studies, 100 μM ArgE was incubated with a preincubated number of metal equivalents for 
20 min at 25 °C before kinetic analyses were performed (Fig. 1). Maximum activity was observed at 
approximately 1 equiv of added Mn(II), with a slight decrease in k cat upon further addition of up to 2 equiv of 
(Mn(II), similar to Zn(II) binding to ArgE [17]. The dissociation constant (K d) for Mn(II) binding to ArgE was 
determined by fitting the activity titration data to Eq. 3 (Fig. 2) [17]:  
 
𝑟𝑟 = 𝑝𝑝CS/(𝐾𝐾d + 𝐶𝐶S)  (3) 
 
where p is the number of sites for which interaction with Mn(II) is governed by the intrinsic dissociation 
constant, K d, and r is the binding function calculated by the conversion of the fractional saturation (f a) using 
Eq. 4:  
 
𝑟𝑟 = 𝑓𝑓a𝑝𝑝 (4) 
 
C S, the free metal concentration, was calculated using Eq. 5:  
 
𝐶𝐶S = 𝐶𝐶TS − 𝑟𝑟𝐶𝐶A,  (5) 
 
where C TS and C A are the total molar concentrations of metal and enzyme, respectively. A value for K d was 
obtained by fitting the data via an iterative process that allowed both K d and p to vary. The best fits obtained 
provided a p value of 1 and a K d value of 0.18 μM.  
 
Table 1. Kinetic constants for the hydrolysis of NAO catalyzed by [Mn(II)_(ArgE)] compared with those for NAO 
catalyzed by [Zn(II)_(ArgE)] and [Co(II)_(ArgE)] [17] 
 
Enzyme form kcat (s−1) Km (mM) kcat/Km (M−1 s−1) 
[Zn(II)_(ArgE)] 1,600 0.8 2.0 × 106  
[Co(II)_(ArgE)] 3,800 1.2 3.2 × 106  
[Mn(II)_(ArgE)] 550 0.8 6.9 × 105  
 
NAON-acetyl-l-ornithine, ArgEargE-encoded N-acetyl-l-ornithine deacetylase 
  
Fig. 1. kcat of a 10 μM sample of apo argE-encoded N-acetyl-l-ornithine deacetylase (ArgE) titrated with 0.2–2.0 
equiv of Mn(II) 
 
  
Fig. 2. Binding function (r) versus the concentration of free metal ions in solution (C S) for Mn(II) titration into 
apo-ArgE (50 mM KHPO4 buffer pH 7.5) 
 
Isothermal titration calorimetry 
ITC measurements were carried out using a MicroCal OMEGA ultrasensitive titration calorimeter at 25 ± 0.2 °C. 
Association constants (K a) were obtained by fitting these data, after subtraction of the background heat of 
dilution, via an interactive process using the Origin software package (Fig. 3). The K a value, enzyme-metal 
stoichiometry (n), and the change in enthalpy (ΔH°) were allowed to vary during the fitting process. For ArgE, K d 
values determined for Mn(II) binding revealed one tight binding site with a K d value of 0.3 μM, while the second 
metal binding site exhibited weaker Mn(II) affinity, with a K d value of 5.3 μM. The thermodynamic properties 
observed for Mn(II) binding were similar to those monitored for Zn(II) binding to ArgE for the first metal binding 
event, which is endothermic. However, the second binding event is also endothermic for Mn(II), but exothermic 
for Zn(II) (Table 2).  
  
Fig. 3. a Isothermal titration calorimetry (ITC) titration of a 70 μM solution of apo-ArgE with a 2.5 mM solution of 
Mn(II). b Fit of the ITC data for ArgE after subtraction of the heat of dilution. Reaction conditions, 25 °C in 
50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer, pH 7.5, and 150 mM KCl 
 
Table 2. Thermodynamic parameters for binding of ArgE to Mn(II) compared with those previously determined 
for binding of ArgE to Zn(II) and Co(II) [17] 
 
Parameter Zn(II) Co(II) Mn(II) 
    
ΔH 1 (kcal mol−1) 4.6 2.2 1.2 
ΔH 2 (kcal mol−1) −2.7 −26.0 2.0 
ΔG 1 (kcal mol−1) −5.9 −8.7 −8.8 
ΔG 2 (kcal mol−1) −7.6 −5.2 −7.2 
ΔS 1 (cal mol−1 K−1) 35 36 33 
ΔS 2 (cal mol−1 K−1) 16 −70 30 
 
Temperature dependence of NAO hydrolysis by Mn(II)-loaded ArgE 
The hydrolysis of NAO by ArgE, loaded with 1 or 2 equiv of manganese, was linear over the temperature range 
15–55 °C. Because V max/[E] = k p (where [E] is the enzyme concentration), in rapid equilibrium, and the ArgE 
concentration was constant throughout the duration of each experiment, thermodynamic parameters for the 
enzyme-catalyzed reaction were determined from an Arrhenius plot (Fig. 4a). The activation energy (E a) for 
[Mn(II)_(ArgE)] is 50.3 kJ mol−1. Determination of E a in this manner allows subsequent resolution of other 
thermodynamic parameters by the following equations: ΔH ‡ = E a − RT, ΔS ‡ = (ΔH ‡ − ΔG ‡)/T and ΔG ‡ = −RTln(k 
cat h/k B T), where k B, h, and R are the Bolzmann, Planck and gas constants, respectively. Therefore, ΔG 
‡ = 58.1 kJ mol−1, ΔH ‡ = 47.8 kJ mol−1, and ΔS ‡ = −34.5 J mol−1 K−1 (Table 3). Similarly, a plot of ln(1/K m) versus 
inverse temperature is linear over the same temperature range (Fig. 4b), so ΔH° was obtained as the negative 
slope times the gas constant. Since, ΔG° = RTln(1/K m) and ΔS° = (ΔH° − ΔG°)/T, the following thermodynamic 
parameters were determined for the Michaelis complex of NAO: ΔG° = 0.5 kJ mol−1, ΔH° = −65.0 kJ mol−1, and 
ΔS° = −220.0 J mol−1 K−1 (Table 3).  
 
  
Fig. 4. Arrhenius plots of N-acetyl-l-ornithine (NAO) hydrolysis (a) and NAO binding (b) by [Mn(II)_(ArgE)] 
 
Table 3. Thermodynamic parameters for the hydrolysis of l-leucinep-nitroanilide by Zn(II)-loaded AAP [47] 
compared with those for the hydrolysis of NAO by [Mn(II)_(ArgE)] and [Zn(II)_(ArgE)] [17] and [Co(II)_(ArgE)] [17] 
 
  [Zn(II)Zn(II)(AAP)] [Mn(II)_(ArgE)] [Zn(II)_(ArgE)] [Co(II)_(ArgE)] 
E + S → ES     
 ΔG° (kJ mol−1) −6.1 0.5 ND ND 
 ΔH° (kJ mol−1) −42.6 −65.0 ND ND 
 ΔS° (J mol−1 K−1) −122.5 −219.9 ND ND 
ES → (ES··EP)‡      
 ΔG ‡ (kJ mol−1) 62.1 58.1 54.8 51.5 
 ΔH ‡ (kJ mol−1) 34.0 47.8 23.2 31.8 
 ΔS ‡ (J mol−1 K−1) −94.2 −34.5 −106 −66.0 
 Ea (kJ mol−1) 36.5 50.3 25.6 34.3 
 
AAP leucine aminopeptidase from Aeromonas proteolytica (Vibrio proteolyticus), ND not determined 
 
Inhibition of Mn(II)-loaded ArgE by bestatin 
The effect of bestatin binding on the [Mn(II)_(ArgE)]-catalyzed NAO hydrolysis was examined. Four data sets of 
kinetic assays repeated in triplicates using six concentrations of NAO (0.1–2.0 mM) were collected at different 
bestatin concentrations (0–500 μM). Plots of inverse velocity versus inverse substrate concentration were 
prepared and fit to the Michaelis–Menten equation for competitive inhibition as described by Cleland [40] 
(Fig. 5). The K m value calculated for NAO hydrolysis in this experiment was 1.0 mM, in good agreement with K m 
measurements of [Mn(II)_(ArgE)], while the K i value for bestatin binding to ArgE was 67 μM. Since bestatin 
binding to other dinuclear metallohydrolases, like AAP has been described as a slow process [41], ArgE was 
preincubated with the appropriate concentrations of bestatin for up to 5 h prior to collection of kinetic data. No 
significant change to the inhibition constant was noted as a function of preincubation time with bestatin.  
   
Fig. 5. Lineweaver–Burke plots, 1/V versus 1/[S] (where [S] is the substrate concentration), representing the 
inhibitory effect of 0, 250, 350, and 500 μM bestatin on NAO hydrolysis catalyzed by [Mn(II)_(ArgE)] 
 
Spectroscopic characterization of Mn(II)-loaded ArgE 
[Mn(II)_(ArgE)] exhibited an EPR spectrum typical of Mn(II) in an uconstrained environment (Fig. 6, spectrum A). 
The spectrum of [Mn(II)Mn(II)(ArgE)] exhibited more fine structure, including prominent features at 
approximately 1,500 G and at approximately 2,150 G (Fig. 6, spectrum B). The origins of these fine-structure 
features were further explored by examining spectra of (1) [Mn(II)Mn(II)(ArgE)] recorded at different 
temperatures (Fig. 7), (2) [Mn(II)Mn(II)(ArgE)] at pH 7.5 and pH 10.0 (Fig. 8), (3) heterodimetallic 
[Mn(II)Zn(II)(ArgE)] (Fig. 6, spectrum C), and (4) [Zn(II)Mn(II)(ArgE)] (Fig. 6, spectrum D). The predominant 
spectral features of [Mn(II)Mn(II)(ArgE)] at pH 7.5 exhibited indistinguishable, and essentially Curie–Weiss law, 
temperature dependencies from 6 to 30 K (Fig. 7). Closer examination of spectra recorded at 12 K showed no 
convincing evidence for Mn(II)–Mn(II) spin–spin coupling in [Mn(II)Mn(II)(ArgE)] at pH 7.5 (Fig. 8, spectra A and 
B), whereas [Mn(II)Mn(II)(ArgE)] at pH 10.0 (Fig. 8, spectra C and D) clearly showed the 45-G splitting expected 
for a dinuclear Mn(II)–Mn(II) center. The EPR spectra of [Mn(II)Zn(II)(ArgE)] (Fig. 6, spectrum C) and 
[Zn(II)Mn(II)(ArgE)] (Fig. 6, spectrum D) were distinct from that of [Mn(II)_(ArgE)] in that intense features due to 
fine structure were observable, though the spectra were different from each other and from that of 
[Mn(II)Mn(II)(ArgE)], particularly in terms of the intensities of the features at 4,000–5,000 G. The origin of the 
features in the spectra of the dimetallic forms of ArgE, other than the six-line g ∼ 2 pattern, were investigated 
via computer simulation (Fig. 9). Subtraction of the spectrum of [Mn(II)_(ArgE)] from that of [Mn(II)Mn(II)(ArgE)] 
yielded the difference spectrum shown in Fig. 9, spectrum A and subtraction of the signal of [Zn(II)Mn(II)(ArgE)] 
from that of [Mn(II)Zn(II)(ArgE)] yielded the difference spectrum shown in Fig. 9, spectrum B. The computed 
spectrum (Fig. 9, spectrum C) assumes a single magnetically isolated Mn(II) ion with the spin-Hamiltonian 
parameters g isotropic = 2.0, A isotropic I=5/2 (55Mn) = 8.8 × 10−3 cm−1, D = 0.093 cm−1, σD = 0.013 cm−1, and E/D = 0.05. 
The spectral density of the [Mn(II)Mn(II)(ArgE)] signal is asymmetric about the baseline in the 2,500–4,500-G 
region, suggesting rapid passage effects at the relatively high microwave field employed. Additional information 
is available from this phenomenon; subtraction of the superficially similar signal of [Mn(II)Zn(II)(ArgE)] from that 
of [Mn(II)Mn(II)(ArgE)] yielded an absorption signal (Fig. 6, spectrum E) in which each of the M S=5/2 manifolds is 
evident. The EPR data, then, show that the Mn(II) ion(s) in the species [Mn(II)_(ArgE)], [Mn(II)Mn(II)(ArgE)], 
[Mn(II)Zn(II)(ArgE)], and [Zn(II)Mn(II)(ArgE)] are distinct. The Mn(II) ions in [Mn(II)Mn(II)(ArgE)] are magnetically 
isolated at physiologically significant pH but exhibit exchange coupling at higher, nonphysiological pH.  
  
Fig. 6. Electron paramagnetic resonance (EPR) spectra of 1 mM samples of [Mn(II)_(ArgE)] (A), 
[Mn(II)Mn(II)(ArgE)] (B), [Mn(II)Zn(II)(ArgE)] (C), and [Zn(II)Mn(II)(ArgE)] (D), recorded at 9.63 GHz, 12 K, 20-mW 
microwave power in 50 mM HEPES buffer, pH 7.5. E A difference spectrum generated by subtracting a 
proportion of C from B  
  
 
Fig. 7. EPR spectra of a 1 mM sample of [Mn(II)Mn(II)(ArgE)] recorded at 9.63 GHz, 20-mW microwave power in 
50 mM HEPES buffer, pH 7.5, at 50 K (A), 20 K (B), and 12 K (C). The temperature dependencies of a low field fine 
structure feature (measured as I D = I 2150 G − I 1660 G), of the high-field line of the central manifold (measured as I 
E = I 6200 G − I 3717 G), and of the high field fine structure feature (measured as I F = I 6200 G − I 4300 G) are plotted as D, 
E, and F, respectively 
  
Fig. 8. Expanded EPR spectra of [Mn(II)Mn(II)(ArgE)] at pH 7.5 (A, B) and pH 10.0 (C, D). A and C show the as-
recorded (9.63 GHz, 12 K, 20 mW) ∂χʺ/∂B spectra, and B and D show the corresponding derivatives, ∂2 χʺ/∂B 2  
 
  
Fig. 9. A difference spectrum obtained by subtracting a proportion of spectrum A from spectrum B of Fig. 6. B 
Generated by subtraction of spectrum D from spectrum C of Fig. 6. C A theoretical spectrum generated using the 
parameters gisotropic = 2.0, A isotropic I=5/2 (55Mn) = 8.8 × 10−3 cm−1, D = 0.093 cm−1, σD = 0.013 cm−1, and E/D = 0.05 
 
Upon the addition of bestatin, the spectra (Fig. 10) of [Mn(II)Mn(II)(ArgE)], [Mn(II)Zn(II)(ArgE)], and 
[Zn(II)Mn(II)(ArgE)] were all significantly perturbed. In each case, the intensity of the fine-structure feature at 
1,200–1,450 G was diminished, and the feature evident in the spectra of untreated enzyme forms at around 
2,100 G was shifted upfield by 200 G to 2,300 G. While the intensity of this feature was lowered upon the 
addition of bestatin in the cases of [Mn(II)Mn(II)(ArgE)] and [Mn(II)Zn(II)(ArgE)], the feature was enhanced for 
[Zn(II)Mn(II)(ArgE)].  
  
Fig. 10. EPR spectra of [Mn(II)Mn(II)(ArgE)] (A), [Mn(II)Zn(II)(ArgE)] (B), and [Zn(II)Mn(II)(ArgE)] (C) after 
incubation with bestatin in 50 mM HEPES buffer, pH 7.5. Spectra were recorded at 9.63 GHz, 12 K, 20-mW 
microwave power 
Discussion 
The arginine biosynthetic pathway offers several potential antibacterial targets that have yet to be explored 
[19]. One of the members of this pathway, ArgE, has been identified in several pathogenic bacteria such as 
E. coli O157:H7, Salmonella typhimurium, Legionella pneumophila, Yersinia pseudotuberculosis, Bordetella 
pertussis, Vibrio cholerae, Staphylococcus aureus, and Mycobacterium tuberculosis [11, 20, 21, 42]. Alignment of 
each of the gene sequences with the structurally characterized dinuclear Zn(II) metallohydrolases AAP and GCP2 
revealed significant sequence homology, especially in the amino acids functioning as metal ligands [21]. 
However, it should be noted that no catalytically important amino acid residues have been identified for any 
ArgE enzyme. Both AAP and CPG2 possess a (μ-aquo)(μ-carboxylato)dizinc(II) core with one terminal carboxylate 
and histidine residue bound to each metal ion [22, 23]. The enzymatic activity of the ArgE from E. coli has 
recently been shown to be dependent on Zn(II) ions similar to AAP and CPG2 [17, 21], but ArgE can also be 
activated by Mn(II) ions, unlike AAP and CPG2 [17]. In an effort to gain insight into the structural and catalytic 
properties of ArgE, we examined the Mn(II)-loaded forms via kinetic, thermodynamic, and spectroscopic 
methods. 
 
ArgE shows nearly optimal kinetic activity in the presence of only 1 equiv of Mn(II). These data are similar to 
those reported for AAP, which exhibits approximately 90% of its total activity in the presence of one Zn(II) ion 
[43]. The k cat and K m values for ArgE loaded with 1 equiv of Mn(II) ([Mn(II)_(ArgE)]) were found to be 550 s−1 and 
0.8 mM, respectively, providing a catalytic efficiency (k cat/K m) of 6.9 × 105 M−1 s−1. The k cat/K m value for Mn(II)-
loaded ArgE is only 2.8 and 4.6 times smaller than that observed for the Zn(II)-loaded enzyme and the Co(II)-
loaded enzyme, respectively, suggesting that Mn(II) provides an ArgE enzyme that is nearly as capable as the 
Zn(II)-loaded form. The fact that ArgE can be activated by a number of first-row transition metal ions in the 
divalent oxidation state is typical for metallohydrolases in the M28 family [11]. However, Mn(II) does not, in 
general, activate these enzymes. For example, AAP cannot be activated by Mn(II) [44]; however, the dapE-
encoded N-succinyl-l,l-diaminopimelic acid desuccinylase (DapE) from Haemophilus influenzae and blLAP, which 
is not a member of the M28 family, can both be activated by Mg(II) and Mn(II) [45]. ArgE shares no sequence 
homology with blLAP, but is 32% identical to AAP and retains all of the amino acid residues that function as 
metal ligands [21]. Such observations suggest ArgE may share structural homology with some enzymes and 
functional homology with others that are structurally distinct. Furthermore, the fact that ArgE is active with such 
a broad range of divalent metal ions suggests it might be critical to bacterial cell survival (i.e., if the cellular 
milieu is limiting in one metal, another can substitute). 
 
Titration of apo-ArgE with Mn(II) confirmed that the enzyme is approximately 90% active after the addition of 
only 1 equiv of Mn(II). Fits of these titration data provided a K d value for the first metal binding site of 180 nM. 
Since only one metal ion is bound to the enzyme active site, these K d values correspond to the microscopic 
binding constants for the binding of a single metal ion to ArgE. This K d value is significantly smaller than that 
observed for Zn(II) binding to ArgE (6 μM), but is similar to K d values obtained for several other hydrolytic 
enzymes that contain mixed histidine-carboxylate active sites. For example, the K d values for the first Zn(II) ion 
binding events in DapE and AAP are 140 and 1 nM, respectively [45]. Verification of the observed K d value for 
the first metal binding site of ArgE was obtained from ITC. ITC measurements of Mn(II) binding to ArgE provided 
K d values of 300 nM for the first metal binding site and 5.3 μM for the second. These data indicate that Mn(II) 
binds 9 times more tightly to the first metal binding site and 10 times more tightly to the second metal binding 
site than Zn(II) [17]. These data suggest that under physiological conditions in the absence of substrate, the 
second metal binding site is potentially only occupied when Mn(II) ions are present. For Mn(II), the first and 
second metal binding events are both endothermic, which differs from the case for both Zn(II) and Co(II), which 
exhibit exothermic first metal binding events and endothermic second metal binding events [17]. Interestingly, 
the Gibbs free energy does not significantly change upon substitution of Zn(II) by Mn(II) or Co(II) and is similar to 
that observed for AAP. Similarly, the entropic factor (ΔS) remains the same for the first metal binding event 
despite a large decrease in K d for Mn(II) and Co(II) binding to ArgE. However, ΔS becomes negative for the 
second Mn(II) and Co(II) binding events but remains slightly positive for the second Zn(II) binding site. These 
data suggest a decrease in order around the second Mn(II) binding site. 
 
Similar to AAP, ArgE binds 2 equiv of Mn(II), with ΔH 1 = 0.3 kJ mol−1 and ΔH 2 = 29.1 kJ mol−1 for AAP and ΔH 
1 = 1.2 kJ mol−1 and ΔH 2 = 2.0 kJ mol−1 for ArgE. The binding affinity for Mn(II) at both sites on the basis of ITC 
measurements is similar for the two enzymes, K d1 = 3.4 μM and K d2 = 39 μM for AAP and K d1 = 0.3 μM and K 
d2 = 5.3 μM for ArgE. However, AAP is not catalytically competent when loaded with Mn(II) [44]. These data 
suggest that Mn(II) may bind to AAP and ArgE in a similar manner, but a Mn(II)-loaded AAP active site may not 
allow proper positioning of substrate for catalysis, while a Mn(II)-loaded ArgE site does. Thus, ArgE may also 
share functional homology with other dinuclear enzymes with which it shares little primary sequence homology, 
like the methionine aminopeptidase type II from Homo sapiens, which has been suggested to employ Mn(II) in 
vivo [46]. Therefore, efficacious pharmaceuticals targeting ArgE must incorporate functional groups that bind 
tightly and specifically to this active site in a variety of metal-loaded forms. 
 
Since ArgE is relatively stable at 45 °C, activation parameters for the ES‡ complex were obtained by examining 
the hydrolysis of NAO as a function of temperature. Construction of an Arrhenius plot from the temperature 
dependence of ArgE activity indicates that the rate-limiting step does not change as a function of temperature. 
The activation energy (E a) for the ES‡ complex of Mn(II)-loaded ArgE is 50.3 kJ mol−1. The observed activation 
energy for Mn(II)-loaded ArgE is significantly larger than the E a values reported for [Zn(II)_(ArgE)] (25.6 kJ mol−1) 
and [Co(II)_(ArgE)] (34.3 kJ mol−1) as well as the E a values reported for AAP (36.5 kJ mol−1) and DapE (31 kJ mol−1) 
[17, 45, 47]. However, substrate binding to [Zn(II)Zn(II)(AAP)] [48] and [Mn(II)Mn(II)(ArgE)] appears to proceed 
by similar processes, since both enzymes are governed by a single rate constant, indicated by the linearity of a 
plot of ln(1/K m) versus 1/T [49]. NAO binding to Mn(II)-loaded ArgE is distinguished by greater heat loss and a 
higher degree of order imposed by Michaelis complex formation. The possibility that the active sites of these 
metal-variant forms of ArgE are structurally different is supported by EPR data. 
 
The EPR spectra of [Mn(II)_(ArgE)], [Mn(II)Mn(II)(ArgE)], [Mn(II)Zn(II)(ArgE)], and [Zn(II)Mn(II)(ArgE)] indicate 
distinct Mn(II) environments in each species (Fig. 6). Comparison of the signals observed for [Mn(II)_(ArgE)] and 
[Mn(II)Zn(II)(ArgE)] reveals a change in the environment of the Mn(II) ion upon binding a second metal ion. 
Subtraction of the signal of [Mn(II)_(ArgE)] from that of [Mn(II)Mn(II)(ArgE)] suggests an additional Mn(II) 
environment in [Mn(II)Mn(II)(ArgE)] that can be reasonably simulated as a magnetically isolated Mn(II) ion 
(Fig. 9). Similarly, subtraction of the signal of [Zn(II)Mn(II)(ArgE)] from that of [Mn(II)Zn(II)(ArgE)] isolated an 
analogous species. The asymmetry of the signal from [Mn(II)Mn(II)(ArgE)] indicated that one, or both, of the 
Mn(II) ions in that species exhibited unusually slow relaxation. This phenomenon was not observed in the other 
species and subtraction of the signal of [Mn(II)Zn(II)(ArgE)] from that of [Mn(II)Mn(II)(ArgE)] confirmed the 
presence of an absorption-like component in the spectrum of the latter. These relatively subtle differences 
between the spectra of each of the species illustrate a very important point; i.e., that both the existence and the 
nature of each metal ion in a dinuclear form of ArgE affects the electronic structure of the other. For example, 
the environment of Mn1 is affected by the binding of Zn ([Mn(II)_(ArgE)] versus [Mn(II)Zn(II)(ArgE)]). The effect 
of binding Mn2 upon the metal center of [Mn(II)Mn(II)(ArgE)] is to yield a slowly relaxing species that is not 
observed for Mn1 in [Mn(II)Zn(II)(ArgE)] or for Mn2 in [Zn(II)Mn(II)(ArgE)]; therefore, the nature of M1 and that 
of M2 influence each other’s electronic structures. Furthermore, the lack of direct magnetic interaction between 
the Mn(II) ions in [Mn(II)Mn(II)(ArgE)] suggests that the mechanisms of these intermetal effects are likely 
structural in nature rather than magnetic. Thus, the active-site geometry in ArgE appears to be unusually 
dependent on the precise metal complement; the fine structure in each of the spectra from Mn(II)-loaded forms 
of ArgE was all assignable to magnetically isolated Mn(II) ions by simulation (Fig. 9) and temperature 
dependence (Fig. 7), and close examination of the fine structure (Fig. 8) provided no evidence for Mn(II)–Mn(II) 
spin coupling at pH 7.5. 
 
The EPR spectrum of [Mn(II)Mn(II)(ArgE)] at pH 10.0 furnished clear evidence of a dinuclear Mn(II)-Mn(II) center, 
with a 45 G-split multiline pattern (Fig. 8). These data strongly suggest that the metal ions in the dinuclear forms 
of ArgE are in close proximity but are not bridged by a ligand capable of mediating exchange coupling at pH 7.5. 
The EPR signal for [Co(II)Co(II)(ArgE)] is not significantly altered between pH 7.5 and 10 [17], suggesting a 
hydroxide ion functions as the nucleophile for this enzyme form. On the other hand, the EPR signal for 
[Mn(II)Mn(II)(ArgE)] demonstrates spin coupling at pH 10, but not at pH 7.5. This suggests a water molecule acts 
as the nucleophile for this enzyme form at physiological pH, while a hydroxide is the nucleophile at pH 10. Such 
structural differences in Mn(II)-loaded ArgE might contribute to misalignment of the carbonyl carbon of 
substrate in the Michaelis complex. This would account for the higher activation energy of the transition state of 
Mn(II)-loaded ArgE compared with that of Co(II)-loaded and Zn(II)-loaded forms. The enthalpy of activation for 
Mn(II)-loaded ArgE at 25 °C is 47.8 kJ mol−1, while the entropy of activation was found to be −34.5 J mol−1 K−1. 
The positive enthalpy is indicative of a conformation change upon substrate binding, likely due to the energy of 
bond formation and breaking during nucleophilic attack on the scissile carbonyl carbon of the substrate. On the 
other hand, the negative entropy values suggest that some of the molecular motions are lost upon ES‡ complex 
formation, possibly owing to hydrogen-bond formation between catalytically important amino acids and the 
substrate. All of these factors contribute to the large positive free energy of activation. 
 
Peptide analog inhibitors of microbiological origin have not been examined with an ArgE enzyme, but one of 
these, bestatin, has been shown to be a competitive, slow-binding inhibitor of both blLAP and AAP, with K i * 
values of 1.3 and 18 nM, respectively [35, 41, 52]. Bestatin is a naturally occurring dipeptide isolated from 
cultures of S. olivoreticuli and the metal binding region of bestatin has been designed into numerous dinuclear 
metallohydrolase inhibitors [52]. X-ray crystallographic data of bestatin-bound complexes of blLAP and AAP have 
been reported [53, 54]. The X-ray crystal structures of both [Zn(II)Zn(II)(blLAP)]–bestatin and [Zn(II)Zn(II)(AAP)]–
bestatin revealed that the N-terminal amino group of bestatin coordinates to Zn2, while the alkoxide moiety 
bridges between the two Zn(II) ions. Interestingly, the backbone carbonyl oxygen of bestatin is not bound to the 
dinuclear metal center in blLAP but is, instead, hydrogen-bonded to the positively charged terminal amine of an 
active-site lysine residue. However, in AAP the backbone carbonyl oxygen of bestatin binds to Zn1. In order to 
determine if the metal binding region of bestatin can bind to the dinuclear active site of ArgE, the K i for bestatin 
binding to Mn(II)-loaded ArgE was measured. Bestatin was found to be a simple competitive inhibitor of 
[Mn(II)Mn(II)(ArgE)], with a K i of 67 μM. The presence or absence of a bridging water/hydroxide in the active 
site of Mn(II)-loaded ArgE was investigated by binding bestatin to [Mn(II)Mn(II)(ArgE)]. Only mild perturbation of 
the signal was observed in the EPR spectrum with bestatin, indicating binding to the active site, but not in a way 
that perturbs exchange coupling. These data indicate that bestatin binds to ArgE in a significantly different way 
from how it binds to AAP or blLAP [53, 54]. While bestatin does not bind ArgE tightly or specifically enough to be 
therapeutically practical, this dipeptide provides a backbone from which other molecules may be synthesized 
with increased and more specific binding affinity to the ArgE active site. 
 
In conclusion, the kinetic and thermodynamic data presented herein provide evidence that two Mn(II) ions can 
bind to ArgE with K d values that differ by a factor of approximately 18. Moreover, ArgE is nearly fully active 
upon the addition of one divalent Mn(II) ion. Therefore, ArgE behaves similarly to AAP where one metal ion is 
the catalytic metal ion, while the second is likely to play a structural role [47]. The spectroscopic data presented 
herein provide the first structural glimpse at the active site of a Mn(II)-loaded ArgE enzyme. EPR spectra of 
[Mn(II)Mn(II)(ArgE)] indicate clear evidence of spin–spin coupling between the two Mn(II) ions, but only at high 
pH values. In addition, bestatin was shown to be a competitive inhibitor of ArgE, but on the basis of EPR data, no 
bridging alkoxide moiety is present in the dimanganese(II) active site of ArgE. These data suggest that bestatin 
binds to ArgE enzymes in a way different from that observed by X-ray crystallography for AAP and blLAP [53, 54]. 
This finding is critical for the future design and synthesis of small molecule inhibitors, based on the metal 
binding components of bestatin that potentially target ArgE enzymes. 
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